Goldman Sachs
NPSP

Goldman Sachs’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Goldman Sachs’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-19,800
Closed -$708K – 7542
2014
Q4 		$708K Sell
19,800
-85,400
-81% -$2.55M ﹤0.01% 4937
2014
Q3 		$2.73M Sell
105,200
-148,300
-59% -$4.26M ﹤0.01% 3622
2014
Q2 		$8.38M Buy
+253,500
New +$7.32M ﹤0.01% 2527
2014
Q1 		– Sell
-13,600
Closed -$413K – 7075
2013
Q4 		$413K Buy
+13,600
New +$375K ﹤0.01% 5447

Other funds holding NPSP

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Goldman Sachs's NPSP Position: Q1 2015 in Review

Goldman Sachs sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 1,243,113 shares — an estimated $44.5M sold.

Goldman Sachs first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $44.5M in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • Goldman Sachs reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Goldman Sachs sold 1,243,113 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $44.5M.
  • Goldman Sachs first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Goldman Sachs's NPS PHARMACEUTICALS INC position peaked at $44.5M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on Goldman Sachs's 13F filing for Q1 2015, filed 15 May 2015.